You are here

PwC to employers: Focus on all medical prices—and not just drug prices

Health plans expected to continue pushing for value-based payment arrangements.

Experts at PricewaterhouseCoopers’s Health Research Institute project that medical costs in the employer insurance market will increase by 6% next year. The good news: that falls within the range of 5.5%–7% that costs have been going up the last several years. Still the year-in, year-out cost increases in health care are not sustainable, says PwC. Efforts to rein in utilization have run their course, according to PwC’s health care experts, so employers need to tackle prices if they want to control their medical costs—and not just drug prices that have been the focus recently.

Source: PricewaterhouseCoopers

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs